Filing Flows › Volitionrx (VNRX) › Q2 2026 › vs Q2 2025
Volitionrx (VNRX) Q2 2026 vs Q2 2025 (year over year)
Volitionrx's revenue fell $8K (-2%) from $407K in Q2 2025 to $399K in Q2 2026.
Volitionrx, Q2 2026: revenue $399K (-2% year over year), net loss $7.3M, operating cash flow −$5.2M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $399K | $407K | −$8K | -2% |
| Net loss | $7.3M | $6.3M | $1.0M | +16% |
| Costs & expenses | $7.7M | $6.7M | $993K | +15% |
| Operating costs | $4.6M | $6.7M | −$2.1M | -32% |
| Interest & other, net | $3.2M | $16K | $3.1M | 194× |
| Research & development | $1.8M | $2.7M | −$920K | -34% |
| Sales & marketing | $549K | $1.0M | −$495K | -47% |
| General & admin | $2.2M | $2.9M | −$735K | -25% |
| Operating cash sources | $7.3M | $6.3M | $1.0M | +16% |
| Depreciation & amortization | $188K | $253K | −$65K | -26% |
| Share-based compensation | $238K | $812K | −$574K | -71% |
| Working capital & other | $1.7M | −$1.0M | $2.7M | — |
| Cash used in operations | $5.2M | $6.3M | −$1.1M | -18% |
| Net loss absorbed | $7.3M | $6.3M | $1.0M | +16% |
Questions
How much did Volitionrx's revenue grow year over year in Q2 2026?
Volitionrx's revenue fell $8K (-2%) from $407K in Q2 2025 to $399K in Q2 2026.